SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 13th, 2018 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 15, 2018, by and between CEREBAIN BIOTECH CORP., a Nevada corporation, with headquarters located at 600 Anton Blvd., Suite 1100, Costa Mesa, CA 92626 (the “Company”), and AUCTUS FUND, LLC, a Delaware limited liability company, with its address at 177 Huntington Avenue, 17th Floor, Boston, MA 02115 (the “Buyer”).
COMMON STOCK PURCHASE WARRANT CEREBAIN BIOTECH CORP.Security Agreement • March 13th, 2018 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $110,000.00 convertible promissory note to the Holder (as defined below) of even date) (the “Note”), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the ”Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Cerebain Biotech Corp., a Nevada corporation (the ”Company”), up to 275,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated February 15, 2018, by and among the Company a
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 13th, 2018 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies • Nevada
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 12, 2018, is entered into by and between CEREBAIN BIOTECH CORP., a Nevada corporation (the “Company”), and EMA Financial, LLC, a Delaware limited liability company (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 13th, 2018 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 14, 2018, by and between CEREBAIN BIOTECH CORP., a Nevada corporation, with headquarters located at 600 Anton Blvd., Suite 1100, Costa Mesa, CA 92626 (the “Company”), and CROWN BRIDGE PARTNERS, LLC, a New York limited liability company, with its address at 1173a 2nd Avenue, Suite 126, New York, NY 10065 (the “Buyer”).
COMMON STOCK PURCHASE WARRANT CEREBAIN BIOTECH CORP.Security Agreement • March 13th, 2018 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of purchase price of $58,500.00, for the first tranche of $65,000.00 under the $130,000.00 convertible promissory note issued to the Holder (as defined below) on February 14, 2018) (the “Note”), Crown Bridge Partners, LLC (including any permitted and registered assigns, the ”Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Cerebain Biotech Corp., a Nevada corporation (the ”Company”), 97,500 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant).
COMMON STOCK PURCHASE WARRANT CEREBAIN BIOTECH CORPCommon Stock Purchase Warrant • March 13th, 2018 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, EMA Financial, LLC, a Delaware limited liability company (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (as defined above) and on or prior to the close of business on the fifth (5th) anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from CEREBAIN BIOTECH CORP., a Nevada corporation (the “Company”), up to 137,500 shares (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b), subject to adjustment herein. This Warrant is issued by the Company as of the date hereof in connection with that certain securities p
